Neil R. Aggarwal

3.8k total citations · 1 hit paper
44 papers, 2.1k citations indexed

About

Neil R. Aggarwal is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, Neil R. Aggarwal has authored 44 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 12 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Neil R. Aggarwal's work include Respiratory Support and Mechanisms (14 papers), Neonatal Respiratory Health Research (13 papers) and COVID-19 Clinical Research Studies (12 papers). Neil R. Aggarwal is often cited by papers focused on Respiratory Support and Mechanisms (14 papers), Neonatal Respiratory Health Research (13 papers) and COVID-19 Clinical Research Studies (12 papers). Neil R. Aggarwal collaborates with scholars based in United States, France and United Kingdom. Neil R. Aggarwal's co-authors include Franco R. D’Alessio, Landon S. King, Kenji Tsushima, Roy G. Brower, Venkataramana K. Sidhaye, Jason R. Mock, Matthew R. Pipeling, Matthew H. Willett, Rubin M. Tuder and John F. McDyer and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Neil R. Aggarwal

38 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diverse macrophage populations mediate acute lung inflammation and resolution

2014 457 citations Neil R. Aggarwal, Landon S. King et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Neil R. Aggarwal United States	22	979	840	504	270	202	44	2.1k
Franco R. D’Alessio United States	27	1.2k 1.2×	1.3k 1.5×	736 1.5×	372 1.4×	204 1.0×	63	3.0k
Kuang‐Yao Yang Taiwan	28	711 0.7×	593 0.7×	477 0.9×	500 1.9×	157 0.8×	96	2.3k
Frank Radella United States	11	695 0.7×	541 0.6×	332 0.7×	352 1.3×	107 0.5×	15	1.6k
Jörg Reutershan Germany	27	606 0.6×	884 1.1×	593 1.2×	231 0.9×	54 0.3×	51	2.4k
Li‐Fu Li Taiwan	23	810 0.8×	235 0.3×	332 0.7×	265 1.0×	115 0.6×	66	1.6k
Baoli Cheng China	25	356 0.4×	431 0.5×	444 0.9×	519 1.9×	121 0.6×	57	1.9k
Jürg Hamacher Germany	28	872 0.9×	288 0.3×	505 1.0×	327 1.2×	98 0.5×	65	2.0k
Nazima Pathan United Kingdom	25	405 0.4×	459 0.5×	1.3k 2.7×	591 2.2×	140 0.7×	79	3.0k
Hidefumi Koh Japan	20	810 0.8×	335 0.4×	278 0.6×	217 0.8×	47 0.2×	36	1.5k
Florian Uhle Germany	22	258 0.3×	419 0.5×	382 0.8×	581 2.2×	222 1.1×	101	1.7k

Countries citing papers authored by Neil R. Aggarwal

Since Specialization

Citations

This map shows the geographic impact of Neil R. Aggarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil R. Aggarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil R. Aggarwal more than expected).

Fields of papers citing papers by Neil R. Aggarwal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil R. Aggarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil R. Aggarwal. The network helps show where Neil R. Aggarwal may publish in the future.

Co-authorship network of co-authors of Neil R. Aggarwal

This figure shows the co-authorship network connecting the top 25 collaborators of Neil R. Aggarwal. A scholar is included among the top collaborators of Neil R. Aggarwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil R. Aggarwal. Neil R. Aggarwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paules, Catharine I., Kathryn Shaw‐Saliba, Judith A. Aberg, et al.. (2025). Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19. BMC Infectious Diseases. 25(1). 67–67. 2 indexed citations

Aggarwal, Neil R., Laurel Beaty, Tellen D. Bennett, et al.. (2024). Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study. The Lancet Regional Health - Americas. 31. 100693–100693. 3 indexed citations

Roberts, Samantha C., Sarah E. Jolley, Laurel Beaty, et al.. (2024). Association between monoclonal antibody therapy, vaccination, and longer‐term symptom resolution after acute COVID‐19. Journal of Medical Virology. 96(3). e29541–e29541.

Molina, Kyle C., Brandon Webb, Laurel Beaty, et al.. (2024). Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5. BMC Infectious Diseases. 24(1). 802–802. 2 indexed citations

Sullivan, Kathleen E., Bruce Thompson, Albert J. Rogers, et al.. (2023). Plasma SARS-CoV-2 Nucleocapsid Antigen Levels Are Associated With In-hospital Mortality in Hospitalized Patients With COVID-19. A6235–A6235.

Molina, Kyle C., Laurel Beaty, Tellen D. Bennett, et al.. (2023). Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5. International Journal of Infectious Diseases. 132. 34–39. 7 indexed citations

Aggarwal, Neil R., Laurel Beaty, Tellen D. Bennett, et al.. (2022). Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients. The Journal of Infectious Diseases. 226(12). 2129–2136. 36 indexed citations

Aggarwal, Neil R., Laurel Beaty, Tellen D. Bennett, et al.. (2022). Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase. International Journal of Infectious Diseases. 128. 310–317. 17 indexed citations

Douin, David J., Adane F. Wogu, Laurel Beaty, et al.. (2022). Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients. BMC Infectious Diseases. 22(1). 818–818. 2 indexed citations

10.

Weinmann, Gail, Thomas L. Croxton, Neil R. Aggarwal, Michael J. Twery, & James P. Kiley. (2019). A Perspective: Division of Lung Diseases at Fifty. American Journal of Respiratory and Critical Care Medicine. 200(12). 1466–1471. 1 indexed citations

11.

Vuga, Louis J., et al.. (2019). Rare Lung Disease Research. CHEST Journal. 156(3). 438–444. 3 indexed citations

12.

Chatterjee, Souvik, Alan N. Baer, Marinos Kontzialis, Neil R. Aggarwal, & Allan C. Gelber. (2015). Searching for the Source: Bacteremia with Marked Cerebrospinal Fluid Pleocytosis. The American Journal of Medicine. 129(1). 44–47. 1 indexed citations

13.

Singer, Benjamin D., Jason R. Mock, Neil R. Aggarwal, et al.. (2014). Regulatory T Cell DNA Methyltransferase Inhibition Accelerates Resolution of Lung Inflammation. American Journal of Respiratory Cell and Molecular Biology. 52(5). 641–652. 82 indexed citations

14.

Aggarwal, Neil R. & Roy G. Brower. (2014). Targeting Normoxemia in Acute Respiratory Distress Syndrome May Cause Worse Short-Term Outcomes because of Oxygen Toxicity. Annals of the American Thoracic Society. 11(9). 1449–1453. 32 indexed citations

15.

Aggarwal, Neil R., Franco R. D’Alessio, Yoshiki Eto, et al.. (2013). Macrophage A2A Adenosinergic Receptor Modulates Oxygen-Induced Augmentation of Murine Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 48(5). 635–646. 23 indexed citations

16.

Aggarwal, Neil R., Eric Chau, Brian T. Garibaldi, et al.. (2013). Aquaporin 5 regulates cigarette smoke induced emphysema by modulating barrier and immune properties of the epithelium. Tissue Barriers. 1(4). e25248–e25248. 21 indexed citations

17.

Garibaldi, Brian T., Franco R. D’Alessio, Jason R. Mock, et al.. (2012). Regulatory T Cells Reduce Acute Lung Injury Fibroproliferation by Decreasing Fibrocyte Recruitment. American Journal of Respiratory Cell and Molecular Biology. 48(1). 35–43. 151 indexed citations

18.

Sidhaye, Venkataramana K., Eric Chau, Vasudha Srivastava, et al.. (2012). A Novel Role for Aquaporin-5 in Enhancing Microtubule Organization and Stability. PLoS ONE. 7(6). e38717–e38717. 27 indexed citations

19.

D’Alessio, Franco R., Kenji Tsushima, Neil R. Aggarwal, et al.. (2009). CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. Journal of Clinical Investigation. 119(10). 2898–2913. 448 indexed citations

20.

Summers, Ronald M., Neil R. Aggarwal, Michael C. Sneller, et al.. (2002). CT Virtual Bronchoscopy of the Central Airways in Patients With Wegener's Granulomatosis. CHEST Journal. 121(1). 242–250. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact